Catalyst Event
Biogen Inc (BIIB) · Other
From KEDI Nvidia Fixed Tech100 Index (KNVDT100)
3/20/2026, 12:00:00 AM
Announced new real-world data at the AD/PD™ 2026 conference showing most Alzheimer's patients continued ongoing therapy with LEQEMBI beyond the initial 18 months of treatment. This data release is expected to have a low price impact of at least 1%, scheduled.
Korean Translation
AD/PD™ 2026 컨퍼런스에서 대부분의 알츠하이머 환자들이 초기 18개월 치료 이후에도 레켐비(LEQEMBI) 치료를 지속했다는 새로운 실제 임상 데이터(real-world data)를 발표함. 이 데이터 발표는 최소 1%의 낮은 주가 영향을 미칠 것으로 예상됨.
Related Recent Events
Adobe Inc (ADBE) · Earnings Release
Adobe's Q2 2026 earnings release is scheduled for June 12, 2026, which is expected to have a high market impact (>=10%) as it provides the next official update on financial performance scheduled.
6/12/2026, 12:00:00 AM
Biogen Inc (BIIB) · Other
U.S. FDA decision on LEQEMBI IQLIK (subcutaneous) for treatment initiation is scheduled. The FDA granted Priority Review for this supplemental Biologics License Application, with a PDUFA action date of May 24, 2026, which is expected. This event is expected to have a high price impact due to the significant market potential of the new delivery method.
5/24/2026, 12:00:00 AM
Rocket Lab Corp (RKLB) · Earnings Release
The next quarterly earnings release on 2026-05-14 is scheduled.
5/14/2026, 12:00:00 AM
COINBASE GLOBAL INC (COIN) · Earnings Release
Coinbase's Q1 2026 earnings release is scheduled for May 7, 2026. Medium importance is estimated as earnings reports are significant events that typically lead to price adjustments, scheduled.
5/7/2026, 12:00:00 AM
Fortinet Inc (FTNT) · Earnings Release
Fortinet's Q1 2026 earnings release is expected on April 30, 2026. Analysts forecast EPS of approximately $0.62 on revenue of $1.73 billion. Medium importance is estimated as earnings releases typically drive significant price movement, estimated.
4/30/2026, 12:00:00 AM
Western Digital Corp (WDC) · Earnings Release
Fiscal third-quarter 2026 earnings release on April 29, 2026, is scheduled. Analysts forecast strong year-over-year growth, with consensus EPS estimates around $2.30-$2.34 forecasted. High impact (≥10%) is estimated and scheduled.
4/29/2026, 12:00:00 AM